Institutional Ownership
Terns Pharmaceuticals Inc
CUSIP 880881107COM430Q1 2026
Institutional Holders
308
13F filers
Shares Held
118.90M
Aggregate institutional
Institutional Value
$5.94B
Q1 2026
Net New Holders
+69
124 new · 55 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions124
Increased114
Decreased52
Sold out55
Institutional Holders
308 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 9.57M | $504.51M | +1.38M | Added |
| 2 | Morgan Stanley | 6.45M | $340.00M | −1.50M | Reduced |
| 3 | Avoro Capital Advisors LLC | 5.70M | $300.24M | +1.34M | Added |
| 4 | Holocene Advisors, LP | 4.12M | $216.99M | +1.34M | Added |
| 5 | Citadel Advisors LLC | 3.22M | $169.70M | +52.2K | Added |
| 6 | Millennium Management LLC | 3.01M | $158.77M | +2.02M | Added |
| 7 | Hbk Investments L P | 2.95M | $155.52M | +2.95M | New |
| 8 | Jpmorgan Chase & Co | 2.87M | $151.75M | +1.10M | Added |
| 9 | Balyasny Asset Management L.P. | 2.78M | $146.53M | +1.89M | Added |
| 10 | Franklin Resources Inc | 2.41M | $127.00M | −322.3K | Reduced |
298 more institutional holders on Premium
See every fund holding Terns Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders